PUBLISHER: The Business Research Company | PRODUCT CODE: 1946984
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946984
Point-of-care diagnostics devices are essential tools designed to assist healthcare professionals in conducting immediate medical diagnostic tests at or in close proximity to the patient's location. These devices are instrumental in providing rapid and on-the-spot information regarding various diseases or health conditions. They find application in a wide range of diagnostic tests, such as measuring glucose and cholesterol levels, electrolyte and enzyme analysis, detecting drugs of abuse, and diagnosing infectious diseases and pregnancy.
The primary categories of point-of-care diagnostic devices and equipment include infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility test kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and various other diagnostic tools. Pregnancy and fertility test kits, for example, are point-of-care diagnostic devices that enable individuals to assess pregnancy and fertility status without the need to visit a healthcare provider. These devices are available in various prescription modes, including prescription-based testing devices and over-the-counter (OTC) testing devices. They serve a diverse range of end-users, including professional diagnostic centers, hospitals and critical care facilities, outpatient healthcare settings, ambulatory care facilities, research laboratories, and homes, contributing to more accessible and immediate healthcare information.
Tariffs are impacting the point-of-care diagnostics devices and equipment market by increasing costs of imported biosensors, test strips, cartridges, microelectronics, and optical components used across diagnostic platforms. Hospitals, diagnostic centers, and home healthcare providers in North America and Europe are most affected due to reliance on imported consumables and devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing per-test costs and slowing device upgrades. However, they are also driving domestic production of consumables, localized device assembly, and innovation in cost-efficient point-of-care diagnostic solutions.
The point-of-care diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides point-of-care diagnostics devices and equipment market statistics, including point-of-care diagnostics devices and equipment industry global market size, regional shares, competitors with a point-of-care diagnostics devices and equipment market share, detailed point-of-care diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care diagnostics devices and equipment industry. This point-of-care diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The point-of-care diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $64.11 billion in 2025 to $71.62 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to growing burden of chronic diseases, increasing demand for rapid clinical decision-making, expansion of outpatient healthcare services, rising adoption of portable diagnostic devices, growth of preventive healthcare practices.
The point-of-care diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $118.72 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing demand for home healthcare diagnostics, rising adoption of digital health ecosystems, expansion of infectious disease screening programs, growing integration of ai-based diagnostic support, increasing focus on remote patient monitoring. Major trends in the forecast period include increasing adoption of rapid diagnostic testing devices, rising demand for decentralized healthcare diagnostics, growing integration of connected point-of-care platforms, expansion of home-based testing solutions, enhanced focus on user-friendly device design.
The growing adoption of mobile health technologies is anticipated to drive the expansion of the point-of-care diagnostics devices market in the coming years. Mobile health refers to the use of mobile devices such as smartphones and tablets, along with other wireless technologies including wearable devices, to deliver healthcare services, share information, and monitor health-related data. Point-of-care diagnostics (POC) devices play an important role in mobile health (mHealth) by enabling fast and convenient testing and data collection at or near the patient's location. These devices are designed to deliver immediate results for a wide range of medical tests and are often integrated with mobile applications or connected to smartphones for data management and transmission. For example, in February 2025, according to PharmiWeb, approximately 23% of healthcare encounters are expected to take place virtually in 2025. Therefore, the increasing adoption of mobile health technologies is contributing to the growth of the point-of-care diagnostics devices market.
Major companies in the point-of-care diagnostic devices and equipment market are developing innovative products such as Cippoint to improve access to healthcare and reduce diagnosis time. Cippoint is a state-of-the-art point-of-care testing device for multiple health conditions, offering a wide range of testing parameters, including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. For instance, in January 2023, Cipla Limited launched Cippoint, an immunofluorescence-based quantitative analyzer that provides rapid test results, enabling healthcare professionals to make clinical decisions more quickly and efficiently in various settings.
In December 2023, Roche, a Switzerland-based provider of in vitro diagnostics, pharmaceuticals, and healthcare solutions, acquired select point-of-care (POC) technology assets from LumiraDx for $295 million. Through this acquisition, Roche seeks to incorporate a versatile, multi-assay point-of-care testing platform into its diagnostics portfolio to expand decentralized testing capabilities in primary care and low-resource settings. LumiraDx is a UK-based company that provides point-of-care diagnostics.
Major companies operating in the point-of-care diagnostics devices and equipment market are Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, Akers Biosciences,
North America was the largest region in the point-of-care diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market. The regions covered in the point-of-care diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the point-of-care diagnostics devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The point-of-care diagnostics market consists of sales of instruments such as pregnancy and fertility testing kits, cholesterol test strips, drug abuse testing kits, and others that are used in point-of-care diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Point-of-Care Diagnostics Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses point-of-care diagnostics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for point-of-care diagnostics devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care diagnostics devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.